Cell fusions and methods of making and using the same

Details Cell fusions and methods of making and using the same Cell fusions and methods of making and using the same

2007-01-24

2009-10-13

Li, Q. Janice (Department: 1633)

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Genetically modified micro-organism, cell, or virus

C424S093100, C424S093700, C435S346000, C435S347000, C435S363000, C435S365100

Reexamination Certificate

active

07601342

ABSTRACT:
The invention is concerned with fusions of dendritic cells and antigen presenting cells. Also provided are methods of making and using these cell fusions, including methods of adoptive immunotherapy. The fusions according to the invention can also be used in methods for antigen discovery.

REFERENCES:
patent: 5348878 (1994-09-01), Rock
patent: 5851756 (1998-12-01), Steinman et al.
patent: 6156307 (2000-12-01), Granucci
patent: 6306388 (2001-10-01), Nair et al.
patent: 6387701 (2002-05-01), Nair et al.
patent: 6652848 (2003-11-01), Gong et al.
patent: 6670186 (2003-12-01), Nair et al.
patent: WO 93/20185 (1993-10-01), None
patent: WO 94/02156 (1994-02-01), None
patent: WO 94/28113 (1994-12-01), None
patent: WO 95/16775 (1995-06-01), None
patent: WO 96/07733 (1996-03-01), None
patent: WO 96/30030 (1996-10-01), None
patent: WO 98/17300 (1998-04-01), None
patent: WO 98/46785 (1998-10-01), None
patent: WO 00/57705 (2000-10-01), None
Albert et al.,Nature, 392:86-89 (1998).
Albert et al.,J. Exp. Med., 188(7):1359-1368 (1998).
Altenschmidt et al.,J. Immunol., 159:5509-5515 (1997).
Austyn,Antigen-Presenting Cells, IRL Press, New York, pp. 28-45 (1990).
Bakker et al.,Cancer Res., 55:5530-5534 (1995).
Banchereau et al.,Nature, 392:246-252 (1998).
Bhardwaj et al.,J. Exp. Med., 175:267-273 (1992).
Bodey et al., “Failure of Cancer Vaccines: The Significant Limitations of this Approach to Immunotherapy”, pp. 2665-2676 (2000).
Cao et al.,Immunol., 97:616-625 (1999).
Carbone et al.,Fundamental Immunology, Second Edition, ed. by William E. Paul, Raven Press Ltd., New York, pp. 541-567 (1989).
Celluzzi et al.,J. Investig. Dermatol., Abstract No. 157, 108: 564 (1997).
Celluzzi et al.,J. Immunol., 160:3081-3085 (1998).
Chen et al.,Proc. Am. Assoc. Cancer Res., Abstract No. 72, 38:11 (1997).
Cohen et al.,J. Exp. Med., 154:1881-1898 (1981).
Delaney et al.,Therapeutic Immunol., 1:153-164 (1994).
Dunnion et al.,Eur. J. Immunol., 25(1):58 (1998).
Fahey et al.,Clin. Exp. Immunol., 88:1-5 (1992).
Fisher et al.,J. Immunol., 130:2666-2670 (1993).
Freeman et al.,Science, 262:909-911 (1993).
Freudenthal et al., Proc.Natl. Acad. Sci. USA, 87:7698-7702 (1990).
Gimmi et al.,Nat. Med., 2:1367-1370 (1996).
Gong et al.,Proc. Am. Assoc. Cancer Res., Abstract No. 1797, 39:263 (1988).
Gong et al.,Gene Therapy, 4:1023-1028 (1997).
Gong et al.,Proc. Am. Assoc. Cancer Res., Abstract No. 4137, 38:616 (1997).
Gong et al.,Proc. Am. Assoc. Cancer Res., Abstract No. 1777, 39:172 (1998).
Gong et al.,Nat. Med., 3:558-561 (1997).
Gong et al.,Proc. Natl. Acad. Sci. USA, 95:6279-6283 (1998).
Gong et al.,J. Immunol., 165:1705-1711 (2000).
Gong et al.,Proc. Natl. Acad. Sci. USA, 97:2715-2718 (2000).
Grabbe et al.,J. Immunol., 146:3656-3661 (1991).
Guo et al.,Science, 263:518-520 (1994).
Houghton et al.,Nat. Med., 4:270-271 (1998).
Hsu et al.,Nat. Med., 2:52-58 (1996).
Hural et al.,J. Immunol., 169:557-565 (2002).
Inaba et al.,J. Exp. Med., 175:1157-1167 (1992).
Inaba et al.,J. Exp. Med., 176:1693-1702 (1992).
Inoue et al.,Cancer Res., 56:4702-4708 (1996).
Janeway Jr.,Immunol. (2001).
Kawashima et al.,Int. J. Cancer, 78:518-524 (1998).
Kikuchi et al.,Cancer Immunol. Immunother., 50:337-344 (2001).
Knight et al.,Proc. Natl. Acad. Sci. USA, 82:4495-4497 (1985).
Komatsubara et al.,Microbiol. Immunol., 32:869-875 (1988).
Krause,J. Immunol., 25:421-428 (2002).
Ladyman et al.,Monoclonal Antibodies: Production, Engineering and Clinical Application, eds. Ritter and Ladyman, pp. 9, 15-17.
Lespagnard et al.,Int. J. Cancer, 76:250-258 (1998).
Mayordomo et al.,Nat. Med., 1:1297-1302 (1995).
Moingeon et al.,Challenges and Issues in New Vaccine Development, 23(4):173-175 (2002).
Mukherji et al.,Proc. Natl. Acad. Sci USA, 92:8078-8082 (1995).
Nabavi et al.,Nature, 360:266-268 (1992).
Ohnishi et al.,Immunol. Cell. Biol., 73:205-211 (1995).
Orscheschek et al.,Eur. J. Immunol., 24:2682-2690 (1994).
Paglia et al.,J. Exp. Med., 178:1893-1901 (1993).
Parkhurst et al.,J. Immunol., 170:5317-5325 (2003).
Powell et al.,J. Immunother. Emphasis Tumor Immunol., 17:209-221 (1995).
Radoja et al., “Cancer-Induced Defective Cytotoxic T Lymphocyte Effector Function: Another Mechanism how Antigenic Tumors Escape Immune-Mediated Killing”, pp. 465-479 (2000).
Riddell et al.,Rev. Med. Virol., 7:181-192 (1997).
Romani et al.,J. Inv. Dermatol., 93:600-609 (1989).
Romani et al.,J. Exp. Med., 180:83-93 (1994).
Rosenberg et al.,Nat. Med., 4:321-327 (1998).
Rosenzwajg et al.,Blood, 87:535-544 (1996).
Sallusto et al.,J. Exp. Med., 179:1109-1118 (1994).
Schiltz et al.,J. Immunother., 20:377-386 (1997).
Schuler et al.,J. Exp. Med., 161:526-546 (1985).
Steinman et al.,J. Exp. Med., 149:1-16 (1979).
Thomas et al.,J. Immunol., pp. 4016-4028 (1994).
Tsai et al.,J. Immunol., 158:1796-1802 (1997).
Wang et al.,J. Immunol., 161:5516-5524 (1998).
Yeh et al.,J. Invest. Dermatol. 109:728-733 (1997).
Young et al.,J. Clin. Invest., 90:29-237 (1992).
Zitvogel et al.,J. Exp. Med., 183:87-97 (1996).
Peters,Immunol., vol. 159(1/2), 14thInternational Leucocyte Conference, Heidelberg (1981).
Somasse et al.,Advances Exper. Med. Biol., 329:299-303 (1993).
Mannering et al., “HLA-DR1-restricted bcr-abl (b3a2)-specific CD4+ T lymphocytes respond to dendritic cells pulsed with b3a2 peptide and antigen-presenting cells exposed to b3a2 containing cell lysates”,Blood, 90(1):290-297 (1997).

Affiliated with

Also associated with

Rating

Cell fusions and methods of making and using the same does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cell fusions and methods of making and using the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cell fusions and methods of making and using the same will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4087041